Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Alpheus Medical has raised $52.0M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Alpheus Medical's investors include OrbiMed, SV Health Investors, Samsara BioCapital, HealthQuest Capital, Brain Tumor Investment Fund.
Alpheus Medical is headquartered in Oakdale, United States.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Alpheus Medical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alpheus Medical — Funding & Investors." VCBacked, May 15, 2025, https://www.vcbacked.co/company/alpheus-medical. Accessed July 31, 2026.
VCBacked. (2025). Alpheus Medical — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/alpheus-medical
{{cite web |title=Alpheus Medical — Funding & Investors |url=https://www.vcbacked.co/company/alpheus-medical |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated